166Ho-FHMA, a new radiopharmaceutical for radiosyno-vectomy; Characterization, animal biodistribution and initial human experience

Clinical Physiology

Volumn 18, Issue 3, 1998, Pages 277-278

  Penttila, P ^a   Makela, O ^a   Hiltunen, J ^a   Haukka, J ^a   Kanckos, S ^a   Komulainen, R ^a  

^a MAP Medical Technologies Oy   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DYSPROSIUM IRON HYDROXIDE DY 165; HOLMIUM; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; CONFERENCE PAPER; DRUG DISTRIBUTION; HEMOPHILIA; HUMAN; NONHUMAN; PRIORITY JOURNAL; RABBIT; SYNOVECTOMY;

EID: 0031806998     PISSN: 01445979     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2281.1998.00038.x     Document Type: Conference Paper

References (1)